10-K: Maximus Reports Strong FY25 Growth, Strategic Streamlining
Annual Report
Maximus, a leading government services provider, reported robust FY25 financial results driven by U.S. Federal Services growth and improved international segment profitability following strategic divestitures.
Summary
- Total revenue increased by 2.4% to $5.43 billion in fiscal year 2025, primarily due to organic growth of 3.9%.
- Net income rose by 3.9% to $319.0 million, and diluted earnings per share (EPS) increased by 10.4% to $5.51.
- The U.S. Federal Services segment saw significant organic revenue growth of 12.1% and a 40.6% increase in operating income, driven by clinical programs and FEMA support.
- The Outside the U.S. segment's operating income surged by 190.6% to $22.4 million, with operating margins improving from 1.2% to 3.7%, largely due to the divestiture of less profitable businesses in Australia and Korea.
- The company repurchased 5.8 million shares of its common stock for $456.6 million in FY25, with $280.8 million remaining under the current $400 million authorization.
- Maximus declared a quarterly dividend of $0.30 per share for Q1 FY26, maintaining its dividend policy.
- The company settled a Civil Investigation Demand related to the Census project for $8.2 million in Q2 FY25.
Sentiment
Score: 8
Explanation: The company demonstrated strong financial performance with significant organic growth in its largest segment (U.S. Federal Services) and substantial margin improvement in its international segment due to strategic divestitures. While the U.S. Services segment saw an anticipated decline, overall profitability and EPS growth were robust. The company's proactive capital allocation through share repurchases and consistent dividends, coupled with a healthy balance sheet and compliance with debt covenants, indicates a strong operational and financial position.
Positives
- Overall revenue grew by 2.4% to $5.43 billion in FY25, with strong organic growth of 3.9%.
- Net income increased by 3.9% to $319.0 million, and diluted EPS grew by 10.4% to $5.51.
- U.S. Federal Services segment revenue increased by 12.1% organically, with operating income up 40.6% to $469.2 million and operating margin expanding to 15.3%.
- Outside the U.S. segment operating income dramatically improved by 190.6% to $22.4 million, with operating margin increasing from 1.2% to 3.7%, reflecting successful strategic divestitures.
- Gross profit percentage improved to 24.6% in FY25 from 23.6% in FY24.
- Adjusted EBITDA increased by 14.1% to $701.6 million, with Adjusted EBITDA margin expanding to 12.9%.
- Adjusted diluted EPS grew by 20.5% to $7.36.
- Strong operating cash flows, enabling significant share repurchases ($447.5 million for 5.8 million shares in FY25).
- Employee engagement improved, with a net promoter score of +36 in FY25 (up from +31 in FY24) and 87% of employees intending to remain with Maximus for at least 12 months.
- Successful resolution of the Census Project Civil Investigation Demand for $8.2 million, consistent with accrual.
- Technology initiatives increased productivity and benefited profit margins in the U.S. Federal Services segment.
- The company remains in compliance with all debt covenants, with a Consolidated Net Total Leverage Ratio of 1.51 and a Consolidated Net Interest Coverage Ratio of 9.25.
Negatives
- U.S. Services segment revenue decreased by 7.7% and operating income declined by 30.7% to $171.3 million, as anticipated, due to the conclusion of higher volumes from Medicaid redetermination activities in FY24.
- Total backlog decreased by 5.2% to $15.3 billion as of September 30, 2025, from $16.167 billion in the prior year.
- Net cash provided by operating activities decreased by $85.9 million (16.7%) to $429.4 million in FY25, driven by movements in cash collections and higher tax payments.
- The effective income tax rate increased to 28.3% in FY25 from 24.5% in FY24, negatively affected by the disposal of businesses in Australia and Korea.
- SG&A expenses increased by 6.2%, including a $39.5 million charge related to the sale of certain Outside the U.S. Segment businesses.
- Interest expense increased by 2.0% due to additional borrowings under the revolving credit facility, despite lower interest rates.
Risks
- Failure to meet performance requirements under contracts could lead to penalties, damages, or contract termination.
- Ability to successfully compete, bid for, and accurately price contracts to generate desired profit.
- Effects of future legislative or government budgetary and spending changes, including prolonged U.S. government shutdowns.
- Impact of U.S. government rules, regulations, executive orders, and non-routine actions on business operations and compliance costs.
- Difficulties in managing growth, including integrating acquired businesses and achieving projected benefits.
- Outcome of reviews or audits, which might result in financial penalties and impair ability to respond to new work invitations.
- Ability to manage capital investments and other contract startup costs.
- Ability to manage debt, especially with variable interest rates.
- Ability to maintain technology systems and protect confidential or protected information.
- Discovery of additional information related to the previously disclosed cybersecurity incident (MOVEit) and potential legal, business, reputational, or financial consequences.
- Ability to attract and retain executive officers, senior managers, and other qualified personnel.
- Effect of union activity and organizing efforts at U.S. locations.
- Government customers not exercising options, recompeting, or terminating contracts on short notice.
- Ability to win recompetes and/or succeed in protests on significant contracts.
- Reliance on a small number of individual contracts and customers (60% of revenue from top 10 contracts, one federal agency accounts for one-fifth of revenue).
- Ability to realize the full value of the $15.3 billion backlog, which is subject to funding, cancellations, and performance factors.
- Failure to comply with laws governing the business, potentially leading to fines, penalties, suspension, or debarment.
- Costs and outcome of litigation, including class actions related to the MOVEit cybersecurity incident.
- Ability to manage third parties (subcontractors, teaming partners) upon whom the company depends.
- Effects of changes in laws and regulations, including tax laws, accounting policies, and macroeconomic conditions.
- Effects of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), on the business, including potential liability, regulatory issues, competition, and reputational damage.
- Liabilities arising from divested or discontinued businesses, including indemnification claims.
- Potential for write-downs, write-offs, restructuring, or impairment charges, particularly for goodwill ($1.78 billion) and intangible assets, if acquisitions do not perform as anticipated.
- Preclusion from bidding and performing certain work due to actual or apparent conflicts of interest.
- Employee or subcontractor misconduct.
- Conflicting or evolving environmental, social, and governance (ESG) expectations from stakeholders.
- Quarterly variations in cash flows and results of operations due to contract timing, caseloads, inflation, budgetary delays, and payment delays.
- Impact of inflation on profitability, especially for fixed-price and performance-based contracts where wage increases may exceed priced escalators.
- Risks of doing business internationally, including foreign currency exchange fluctuations, tax changes, non-compliance with international laws, and geopolitical events.
- Disruptions to operations due to natural disasters, pandemics, global conflicts, or other man-made factors outside of control.
- Inaccurate, misleading, or negative media coverage affecting reputation and ability to bid for government contracts.
- Anti-takeover provisions in Articles of Incorporation and bylaws.
Future Outlook
Maximus expects its effective tax rate for fiscal year 2026 to be between 25.0% and 26.0%, with a favorable cash flow impact anticipated from the One Big Beautiful Bill Act (OBBBA). The company projects U.S. Federal Services segment operating margins for fiscal year 2026 to range between 15.5% and 16%, U.S. Services segment operating margins between 10% and 11%, and Outside the U.S. segment operating margins between 3% and 5%. The company intends to continue paying regular cash dividends, subject to Board discretion and financial factors. States may make changes to programs in anticipation of OBBBA changes, with the nature, extent, and timing still uncertain for FY26.
Management Comments
- Our business has grown organically, mostly from the expansion of our U.S. Federal Services Segment.
- The sale [of Australia and Korea businesses], and similar sales made in fiscal year 2024, have streamlined our international businesses and resulted in improved results in our Outside the U.S. Segment.
- Our operating cash flows remain strong and our overall leverage is relatively low, allowing us to make significant purchases of our own common stock.
- We anticipate operating margins for the U.S. Federal Services Segment in fiscal year 2026 to range between 15.5% and 16%.
- As anticipated, our results [in U.S. Services] have returned to a steady state with the conclusion of this additional work [Medicaid redetermination activities].
- We anticipate operating margins for the U.S. Services Segment in fiscal year 2026 to range between 10% and 11%.
- We anticipate operating margins for the Outside the U.S. Segment in fiscal year 2026 to range between 3% to 5%.
- We believe that our current cash position, access to our revolvers, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund required long-term debt repayments, dividends, and any share purchases we might choose to make.
- We believe we have access to sufficient funds to manage through another shutdown of the U.S. federal government.
- Our near-term capital allocation plan continues to prioritize reducing our debt using our free cash flow.
Industry Context
Maximus operates in the growing industry of tech-enabled services for government agencies, benefiting from increasing demand, constrained government budgets, and a focus on technology modernization. The company's strategic priorities align with broader trends in public service delivery, including citizen-centric services, automation of complex health processes, and advanced technology adoption like AI and machine learning. Legislative changes, such as the OBBBA, create new opportunities and challenges for government contractors in health and human services programs like Medicaid and SNAP, requiring rapid adaptation and specialized expertise. The competitive landscape includes large international firms and smaller specialized companies, with competition often based on comprehensive solutions, price, and past performance.
Comparison to Industry Standards
- The company's stock performance is compared against the S&P MidCap 400 Value Index.
- The company's stock performance is compared against the S&P 400 Commercial & Professional Index.
- The company's stock performance is compared against a peer group comprising Booz Allen Hamilton Holding Corporation, CACI International Inc., Conduent, Inc., ICF International, Inc., Leidos, Inc., and Science Applications International Corporation (SAIC).
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- Ongoing class action and individual lawsuits related to the Q3 FY23 MOVEit cybersecurity incident, centralized in a Multidistrict Litigation (MDL) in the District of Massachusetts, with approximately half of the claims against Maximus remaining after a partial dismissal on July 31, 2025.
- Settled a Civil Investigation Demand from the U.S. Department of Justice regarding the Census project for $8.2 million in the second quarter of fiscal year 2025.
- A lawsuit challenging the inclusion of a labor harmony agreement and related requirements in a CMS CCO contract reprocurement was voluntarily dismissed without prejudice in November 2024 after CMS cancelled the early reprocurement.
Stakeholder Impact
- Shareholders benefited from increased diluted EPS ($5.51), consistent quarterly dividends ($0.30/share), and significant share repurchases ($456.6 million).
- Employees experienced improved engagement (+36 net promoter score), high retention intent (87%), and ongoing investment in talent development and competitive total rewards programs.
- Customers (Government Agencies) received improved service delivery through tech-enabled solutions, clinical services, and technology modernization, particularly in U.S. Federal Services.
- Citizens/Beneficiaries saw improved delivery of public services for over 100 million American citizens and others in the U.K., Canada, and the Middle East, including health insurance eligibility, medical assessments, and employment services.
- Creditors are positively impacted by the company's compliance with all debt covenants, indicating sound financial management of its $1.35 billion debt.
Next Steps
- Continue to monitor and adapt to legislative changes, particularly the implementation of the One Big Beautiful Bill Act (OBBBA) provisions for Medicaid and SNAP, effective December 31, 2026, and fiscal year 2028, respectively.
- Department of Health and Human Services to release final rules for OBBBA Medicaid provisions by June 1, 2026.
- Prioritize reducing debt using free cash flow as part of the near-term capital allocation plan.
- Continue executing the $400 million stock repurchase program, with $280.8 million remaining as of September 30, 2025.
- Maintain focus on strategic priorities: tech-enabled customer service, future of health, and technological modernization, including investments in AI and machine learning.
- File the definitive proxy statement for the 2026 annual meeting of shareholders within 120 days after September 30, 2025.
- Assess the effect of new accounting standards, ASU 2023-09 (Income Taxes) and ASU 2025-06 (Internal-Use Software), on financial statements.
Key Dates
| Date | Description |
|---|---|
| September 30, 2020 | Baseline for stock performance graph. |
| September 30, 2022 | Balance sheet date for accumulated other comprehensive loss. |
| March 2023 | Sale of UK commercial practice and Swedish subsidiary. |
| July 31, 2023 | MOVEit cybersecurity incident occurred. |
| August 1, 2023 | Class action lawsuit (Bishop v. Maximus Federal Services) filed related to MOVEit incident. |
| September 6, 2023 | Individual action (Taylor v. Maximus Federal Services) filed in Florida state court related to MOVEit incident. |
| November 2023 | Sale of businesses in Italy, Singapore, and Canada employment services. |
| February 14, 2024 | Acquisition of IT vendor for $18.0 million. |
| December 2024 | Board authorized $200 million stock purchase program (superseded). |
| December 2024 | Sale of businesses in Australia and Korea. |
| March 20, 2025 | First Amendment to Amended and Restated Credit Agreement. |
| March 31, 2025 | Aggregate market value of outstanding voting stock held by non-affiliates was $3,801,184,315. |
| June 10, 2025 | Amended and Restated By-laws effective. |
| July 1, 2025 | Annual goodwill impairment test performed. |
| July 4, 2025 | Public Law 11921 (One Big Beautiful Bill Act OBBBA) signed into law. |
| July 31, 2025 | Court granted partial dismissal of claims against bellwether defendants in MOVEit MDL. |
| September 2025 | Board authorized increase to stock purchase program up to $400 million (superseded prior authorizations). |
| September 30, 2025 | Fiscal year end. |
| October 6, 2025 | Board declared quarterly cash dividend of $0.30 per share. |
| October 20, 2025 | 30 holders of record of common stock. |
| November 12, 2025 | 54,461,507 shares of common stock outstanding. |
| November 14, 2025 | Record date for Q1 FY26 dividend. |
| November 20, 2025 | Date of KPMG LLP report, CEO/CFO certifications, and signing of 10-K. |
| December 1, 2025 | Payment date for Q1 FY26 dividend. |
| June 1, 2026 | Department of Health and Human Services scheduled to release final rules for OBBBA Medicaid provisions. |
| September 30, 2026 | Expiry of Term Loan B hedge. |
| December 31, 2026 | Effective date for OBBBA Medicaid eligibility changes (redeterminations, work/community engagement). |
| September 30, 2027 | Expiry of Term Loan A hedge and Term Loan B hedge. End of Performance Period for PSUs. |
| Fiscal Year 2028 | Federal funding reductions for SNAP programs under OBBBA scheduled to take effect. |
| May 30, 2029 | Maturity of Term Loan A facility. |
| May 30, 2031 | Maturity of Term Loan B facility. |
Recommendation
buyMaximus's FY25 results demonstrate strong operational execution and strategic clarity. The significant organic growth in the U.S. Federal Services segment, coupled with the successful streamlining and margin improvement in the Outside the U.S. segment, highlights the company's ability to adapt and grow in its core markets. While the U.S. Services segment experienced an anticipated decline, this was a known factor. The robust increase in diluted EPS and Adjusted EBITDA, along with a healthy balance sheet, strong cash flow generation, and a commitment to shareholder returns through dividends and share repurchases, makes Maximus an attractive investment. The company's focus on tech-enabled services, health, and modernization aligns with long-term government demand, suggesting continued growth potential despite regulatory and competitive risks. The current valuation appears favorable given the solid performance and positive outlook for key segments.
Keywords
Maximus, Government services, SEC filing, 10-K, Financial results, U.S. Federal Services, U.S. Services, Outside the U.S., Healthcare programs, Social services, Technology solutions, Artificial intelligence (AI), Machine learning (ML), Cybersecurity, Contract management, Public policy, Stock repurchase, Dividends, Corporate governance, Risk management, Medicaid, ACA, VA medical disability examinations, Business process services (BPS), Financial reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.